Key Voluntary Medical Male Circumcision Characteristics and Outcomes From Varemba Camp, Zimbabwe, August 1, 2017–September 6, 2017 (N=657)
| Age Group | |||||||
|---|---|---|---|---|---|---|---|
| 10–14 | 15–19 | 20–24 | 25–29 | 30–49 | 50+ | Total | |
| HIV status, No. (%) | |||||||
| HIV-negative | 224 (34.1) | 148 (22.5) | 118 (18.0) | 73 (11.1) | 89 (13.5) | 1 (0.2) | 653 (99.4) |
| HIV-positive | 1 (0.2) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 3 (0.5) | 0 (0.0) | 4 (0.6) |
| Unknown | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Male circumcision method, No. (%) | |||||||
| Dorsal slit | 225 (34.2) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 225 (34.2) |
| Forceps-guided | 0 (0.0) | 148 (22.5) | 118 (18.0) | 73 (11.1) | 92 (14.2) | 1 (0.2) | 432 (65.7) |
| Moderate or severe adverse events, No. (%) | 1 (0.2) | 0 (0.0) | 2 (0.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 3 (0.5) |
| Clients with ≥1 postoperative visit within 14 days of procedure, No. (%) | 225 (34.2) | 148 (22.5) | 118 (18.0) | 73 (11.1) | 92 (14.2) | 1 (0.2) | 657 (100.0) |
| Total, No. (%) | 225 (34.2) | 148 (22.5) | 118 (18.0) | 73 (11.1) | 92 (14.2) | 1 (0.2) | 657 (100.0) |